Clinical Trial Update: Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency

View source ↗

Summary

Clinical trial registry update indicating ongoing recruitment for male patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Congenital Adrenal Hyperplasia | Status: RECRUITING